Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy.
暂无分享,去创建一个
B. Maron | D. Aeppli | D. Hurrell | S. Casey
[1] D. Black. Therapeutic targets in cardiovascular disease: a case for high-density lipoprotein cholesterol. , 2003, The American journal of cardiology.
[2] B. Maron,et al. Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy. , 2003, The American journal of cardiology.
[3] B. Maron. Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.
[4] H Niimura,et al. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. , 2001, Journal of the American College of Cardiology.
[5] J. Seidman,et al. The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.
[6] P. Elliott,et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy , 2001, The Lancet.
[7] P. Elliott,et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.
[8] B. Maron,et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. , 2000, Circulation.
[9] B. Maron,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[10] H. Watkins. Sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[11] B. Maron,et al. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. , 1999, JAMA.
[12] A. Moss,et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome : A statement for healthcare professionals from the councils on clinical cardiology, cardiovascular dis , 1998, Circulation.
[13] M. Komajda,et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. , 1998, European heart journal.
[14] B. Maron,et al. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.
[15] H Niimura,et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.
[16] M. Komajda,et al. Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy. , 1998, European heart journal.
[17] M. Komajda,et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. , 1997, Circulation.
[18] W. Mckenna,et al. The management of hypertrophic cardiomyopathy. , 1997, The New England journal of medicine.
[19] B. Maron,et al. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.
[20] B. Maron,et al. Images in cardiovascular medicine. Extreme left ventricular hypertrophy. , 1995, Circulation.
[21] M. Komajda,et al. Molecular basis of familial cardiomyopathies. , 1995, Circulation.
[22] B. Maron,et al. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. , 1993, The American journal of cardiology.
[23] W. Roberts,et al. Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation. , 1993, The American journal of cardiology.
[24] M. Z. Berisso,et al. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. , 1989, The New England journal of medicine.
[25] B. Maron,et al. Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy. , 1989, Journal of the American College of Cardiology.
[26] R L Popp,et al. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. , 1988, Journal of the American College of Cardiology.
[27] B. Maron,et al. Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. , 1987, Journal of the American College of Cardiology.
[28] R. Bonow,et al. Hypertrophic cardiomyopathy. , 1987, Disease-a-month : DM.
[29] B. Maron,et al. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. , 1986, The New England journal of medicine.
[30] W. Williams,et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.
[31] B. Maron,et al. Hypertrophic cardiomyopathy: a discussion of nomenclature. , 1979, The American journal of cardiology.
[32] A. DeMaria,et al. Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.